Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial
Clinical trial NCT05408546 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05408546
- Sponsor
- Translational Sciences, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-24
- Primary completion
- 2026-08-31
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.